Reporte zur Charge PFIZER EN203

Symptomtext

unable to stand; L shoulder/arm chest pain; arm pain; chest pain; significant dizzy spells; chills; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN6203, expiry date not reported), via an unspecified route of administration on 26Feb2021 16:15 at single dose for covid-19 immunisation. Medical history included chronic obstructive pulmonary disease and coronary artery disease from an unknown date and unknown if ongoing. Concomitant medication included tamsulosin, metoprolol tartrate, atorvastatin calcium, rivaroxaban, cyanocobalamin (B12). The patient previously took levaquin and experienced allergies. The patient was 78-years-old when he received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EM9809, expiry date not reported) on 05Feb2021 16:15 on the right arm for covid-19 immunisation. The patient experienced unable to stand, L shoulder/arm, chest pain, arm pain, significant dizzy spells and chills on 27Feb2021 03:00 with outcome of recovered. The events resulted in emergency room/department or urgent care and hospitalization. The patient was hospitalized for the events for 2 days. The patient underwent lab tests and procedures which included chest x-ray: unknown results, electrocardiogram: unknown results, nitrate compound therapy: unknown results, sars-cov-2 test: negative on 27Feb2021. Therapeutic measures were taken as a result of the events. The patient recovered from the events on an unspecified date.